Confidentiality and Privacy: Your treatment and financial details remain confidential as we work directly with your private insurance provider
Conditional Breakthrough : For appropriately selected patients with access to comprehensive care and financial resources, GLP-1 agonists offer genuinely transformative therapeutic benefits
First, use our free wellness platform to find out what your BMI is
Deacon CF, Johnsen AH, Holst JJ
Several brands are already moving early and establishing clear positioning in this emerging category
Some GLP-1 medications have demonstrated cardiovascular protective effects in specific populationsliraglutide, semaglutide injection, and dulaglutide have shown cardiovascular outcome benefits, with Wegovy (semaglutide) recently receiving an FDA indication for cardiovascular risk reduction in adults with established cardiovascular disease and either overweight or obesity